Feature clusters | Features | Included in which models |
---|---|---|
Demographics | Sex at birth (male, female), age at index date | All |
Race/ethnicity | Hispanic, Asian, Black or African American, White | All |
Comorbidities | Hypertension, renal disease, liver disease, cerebrovascular disease, bleeding disorder, organ transplant | All |
Bleeding history | History of bleeding | All |
Socioeconomic | Highest education level achieved (no high school degree, high school graduate, college 1–3 years, college 4 or more years or advanced degree), employed for wages or self-employed, annual household income (< 10 k, 10-25 k, 25-35 k, 35-50 k, 50-75 k, 75-100 k, 100-150 k, 150-200 k, ≥ 200 k), health insurance | All |
Alcohol use | At least once: alcohol drinking | All |
Smoking | 100 cigarettes lifetime At least once: cigar smoking, electronic smoking, hookah smoking, smokeless tobacco | All |
Recreational drug use | At least once: cocaine, hallucinogens, inhalants, marijuana, methamphetamine, prescription opioids, stimulants, sedatives, street opioids | All |
Concurrent drug use: antithrombotics | Clopidogrel, warfarin, apixaban, rivaroxaban, dabigatran, edoxaban, ticagrelor, prasugrel, dipyridamole, ticlopidine, eptifibatide, aspirin (low dose) | All |
Concurrent drug use: non-steroidal anti-inflammatory drugs (NSAIDs) | Aspirin (high dose), ibuprofen, indomethacin, naproxen, mefenamic acid, ketorolac, meloxicam, celecoxib, diclofenac | All |
Concurrent drug use: glucocorticoids | Prednisone, prednisolone, methylprednisolone, dexamethasone, hydrocortisone | All |
Health literacy | Brief Health Literacy Screen | All |
Current SSRI use | Citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, vortioxetine | Combined SSRIs models |
SSRI used just before the newly prescribed SSRI | None, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, vortioxetine | Combined SSRIs models |
Number of prior SSRI switches | Number of switches | Combined SSRIs models |